Literature DB >> 2048289

Vaccination of cows with rough Escherichia coli mutants fails to protect against experimental intramammary bacterial challenge.

A W Hill1.   

Abstract

Vaccination of cows with rough Escherichia coli mutants fails to protect against experimental intramammary bacterial challenge. Vaccine A, a heat-killed Re mutant of strain K12, (UB 1574), was administered as a single parenteral and local dose to 5 cows with 3 control animals and Vaccine B, a heat-killed mutant of O111:B4 (J5) was administered as three parenteral doses into 5 cows with 5 control animals. Following intramammary challenge with a smooth wild-type strain (P4), an acute, severe clinical mastitis developed in all 14 quarters (9 vaccine A and 5 vaccine B) of the vaccinated animals which was indistinguishable from that in the 11 quarters of the control animals. Following vaccine B there was an elevation in serum IgG1 and IgG2 antibody to the common core antigen of endotoxin which, in contrast to the control animals, showed a further increase after intramammary infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2048289     DOI: 10.1007/bf00497785

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  15 in total

1.  Studies on the control of coliform mastitis in dairy cows.

Authors:  A J Bramley; F K Neave
Journal:  Br Vet J       Date:  1975 Mar-Apr

2.  The estimation of the bactericidal power of the blood.

Authors:  A A Miles; S S Misra; J O Irwin
Journal:  J Hyg (Lond)       Date:  1938-11

Review 3.  Pathophysiological effects of endotoxins in ruminants. 1. Changes in body temperature and reticulo-rumen motility, and the effect of repeated administration.

Authors:  J A Lohuis; J H Verheijden; C Burvenich; A S van Miert
Journal:  Vet Q       Date:  1988-04       Impact factor: 3.320

4.  Relationship between serologic recognition of Escherichia coli 0111:B4 (J5) and clinical coliform mastitis in cattle.

Authors:  J W Tyler; J S Cullor; B I Osburn; R B Bushnell; B W Fenwick
Journal:  Am J Vet Res       Date:  1988-11       Impact factor: 1.156

5.  Treatment of gram-negative bacteremia with antiserum to core glycolipid II. A controlled trial of antiserum in patients with bacteremia.

Authors:  J A McCutchan; E J Ziegler; A I Braude
Journal:  Eur J Cancer       Date:  1979       Impact factor: 9.162

6.  The nature of the local immune system of the bovine mammary gland.

Authors:  T J Newby; J Bourne
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

7.  Clinical aspects of coliform mastitis in the bovine.

Authors:  U Weigt
Journal:  Vet Res Commun       Date:  1983-12       Impact factor: 2.459

8.  The use of antilipopolysaccharide (anti-LPS) antibodies in the management of septic shock. A preliminary report.

Authors:  S L Gaffin; E Lachman
Journal:  S Afr Med J       Date:  1984-02-04

9.  Selective transport of serum-derived IgA into mucosal secretions.

Authors:  R F Sheldrake; A J Husband; D L Watson; A W Cripps
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

10.  Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

Authors:  E J Ziegler; J A McCutchan; J Fierer; M P Glauser; J C Sadoff; H Douglas; A I Braude
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

View more
  3 in total

1.  Milk and serum J5-specific antibody responses, milk production change, and clinical effects following intramammary Escherichia coli challenge for J5 vaccinate and control cows.

Authors:  David J Wilson; Bonnie A Mallard; Jeanne L Burton; Ynte H Schukken; Yrjo T Gröhn
Journal:  Clin Vaccine Immunol       Date:  2007-04-25

2.  Beta-hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli.

Authors:  Navit Grinberg; Sharon Elazar; Ilan Rosenshine; Nahum Y Shpigel
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

Review 3.  Progress towards the Elusive Mastitis Vaccines.

Authors:  Pascal Rainard; Florence B Gilbert; Rodrigo P Martins; Pierre Germon; Gilles Foucras
Journal:  Vaccines (Basel)       Date:  2022-02-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.